Anthony Letai: 665 Cancer Models Aim to Accelerate the Next Generation of Drug Discovery
Anthony Letai/biologicalsciences.uchicago.edu

Anthony Letai: 665 Cancer Models Aim to Accelerate the Next Generation of Drug Discovery

Anthony Letai, Director of the National Cancer Institute, shared on X:

“The decade-long, NCI-led Human Cancer Model Initiative published a global public resource in Nature earlier this month.

We are sharing 665 next-gen patient models-representing rare, pediatric, and diverse ancestries-to accelerate drug discovery.”

Anthony Letai: 665 Cancer Models Aim to Accelerate the Next Generation of Drug Discovery

Title: A compendium of next-generation patient-derived models for diverse cancers

Authors: Dina ElHarouni, Mushriq Al-Jazrawe, Seongmin Choi, Merve Dede, Toshinori Hinoue, Sean A. Misek, Heeju Noh, Luca Zanella, Yuen-Yi Tseng, Hayley E. Francies, Dennis Plenker, Cindy W. Kyi, Julyann Perez-Mayoral, Megan J. Stine, Eva Tonsing-Carter, Rachana Agarwal, Jean Claude Zenklusen, James M. Clinton, Jennifer M. Shelton, Timothy R. Chu, William F. Hooper, Xavi Loinaz, Paula Keskula, Jordan Tagle, The HCMI Network, Jesse S. Boehm.

Anthony Letai: 665 Cancer Models Aim to Accelerate the Next Generation of Drug Discovery

Read The Full Article.

Other articles about Human Cancer Model Initiative on OncoDaily.